Eight Contributing Factors to Increasing Heart Disease Incidence in Some Global Regions | Docwire News
The rise in these regions is despite the overall global decline in incidences.
The rise in these regions is despite the overall global decline in incidences.
Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP)…
Dr. Rogers debated against Inhye Ahn, MD, on whether therapy with Bruton tyrosine kinase inhibitors can be discontinued for patients with CLL.
The phase 3 SKYSCRAPER-01 study did “not reach the primary endpoint of overall survival at the final analysis,” according to Genentech, a member of the…
Amy Pierre, RN, BSN, ANP-BC, shares her insights on disparities in multiple myeloma and the steps APPs can take to address them.
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
This American Gastroenterological Association (AGA) living guideline is intended to support practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC).
ASCO’s updated guidelines emphasize integrating palliative care into oncology, highlighting challenges in workforce and equitable access.
AbstractBackgroundThe risk of cardiovascular disease (CVD) is increased in individuals with type 2 diabetes mellitus (T2DM), but it remains uncertain how long an elevated CVD…
AbstractBackgroundNearly one-half of patients admitted with acute decompensated heart failure (ADHF) are discharged with unresolved congestion, elevating rehospitalization risk. This may be due to …
AbstractCurrent evidence indicates that dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor is essential for the prevention of thrombotic events after percutaneous coronary interventions….